ACOR Financial Facts

Net loss per share-basic (earnings per share): 0.09
Total net revenues: 148.2M
See Full Income Statement

Total current assets: 429.57M
Current portion of deferred license revenue: 9.06M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date 2/11/16 EPS Growth Rate -52.2%
Average EPS % Beat Rate +106.2% Revenue Growth Rate +8.8%
Average % Move 1-Wk after EPS +3.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/11/16 Q415 N/A$0.22 N/A N/A$128.24M N/A N/A N/A
10/22/15 Q315 $0.31$0.15 +$0.16$148.2M$115.52M N/A Details
7/30/15 Q215 $0.31$0.17 +$0.14$105.5M$110.84M N/A Details
2/12/15 Q414 $0.46$0.14 +$0.32$117.9M$110.8M N/A Details
4/30/15 Q115 $0.15$0.14 +$0.01$99.85M$100.2M N/A Details
10/30/14 Q314 $0.28$0.05 +$0.23$106M$94.7M N/A Details
7/31/14 Q214 $0.42$0.15 +$0.27$97.13M$91.4M N/A Details
11/4/11 Q311 $0.40$0.73 -$0.33$93.03M$90.78M N/A Details